Clinical Trial Update: A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia [Phase 1, Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 1/2 pilot clinical trial evaluating EM-1421 for the treatment of cervical intraepithelial neoplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia

Drugs mentioned

• EM-1421 (EM-1421)

Snippet

Sponsor: Erimos Pharmaceuticals | Conditions: Cervical Intraepithelial Neoplasia | Phase 1, Phase 2 | Status: COMPLETED